Pages that link to "Q48145193"
Jump to navigation
Jump to search
The following pages link to Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin. (Q48145193):
Displaying 7 items.
- Low-dose methotrexate in myeloproliferative neoplasm models (Q47135834) (← links)
- Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer (Q47350013) (← links)
- Recent Advances in Indazole-Containing Derivatives: Synthesis and Biological Perspectives (Q58115423) (← links)
- The natural polyphenol curcumin induces apoptosis by suppressing STAT3 signaling in esophageal squamous cell carcinoma (Q59792378) (← links)
- Discovery of Soft-Drug Topical Tool Modulators of Sphingosine-1-phosphate Receptor 1 (S1PR1) (Q64268323) (← links)
- Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase (Q94453408) (← links)
- Kinase inhibition in autoimmunity and inflammation (Q100737257) (← links)